Literature DB >> 30718191

Mortality and risk factor analysis for Candida blood stream infection: A multicenter study.

Hideaki Kato1, Yukihiro Yoshimura2, Yoshihiro Suido3, Hiroyuki Shimizu4, Kazuo Ide5, Yoshifumi Sugiyama6, Kasumi Matsuno7, Hideaki Nakajima8.   

Abstract

Candida blood stream infection (candidemia) is severe systemic infection mainly develops after intensive medical cares. The mortality of candidemia is affected by the underlying conditions, causative agents and the initial management. We retrospectively analyzed mortality-related risk factors in cases of candidemia between April 2011 and March 2016 in five regional hospitals in Japan. We conducted bivariate and multivariate analysis of factors including causative Candida species, patients' predisposing conditions, and treatment strategies, such as empirically selected antifungal drug and time to appropriate antifungal treatment, to elucidate their effects on 30-day mortality. The study enrolled 289 cases of candidemia in adults. Overall 30-day mortality was 27.7%. Forty-nine cases (17.0%) were community-acquired. Bivariate analysis found advanced age, high Sequential Organ Failure Assessment (SOFA) score, and prior antibiotics use as risk factors for high mortality; however community-acquired candidemia, C. parapsilosis candidemia, obtaining follow-up blood culture, and empiric treatment with fluconazole were associated with low mortality. Logistic regression revealed age ≥65 years (adjusted odds ratio, 2.13) and sequential organ failure assessment (SOFA) score ≥6 (6.30) as risk factors for 30-day mortality. In contrast, obtaining follow-up blood culture (0.38) and empiric treatment with fluconazole (0.32) were found to be protective factors. The cases with candidemia in associated with advanced age and poor general health conditions should be closely monitored. Obtaining follow-up blood culture contributed to an improved prognosis.
Copyright © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aging; Antifungal stewardship; Community-acquired fungemia; Follow-up blood culture; Multi-drug resistant organisms; Sequential organ failure assessment score

Mesh:

Substances:

Year:  2019        PMID: 30718191     DOI: 10.1016/j.jiac.2019.01.002

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  12 in total

1.  Hospital outbreak of fluconazole-resistant Candida parapsilosis: arguments for clonal transmission and long-term persistence.

Authors:  Arnaud Fekkar; Marion Blaize; Adrien Bouglé; Anne-Cécile Normand; Audrey Raoelina; Dimitri Kornblum; Laure Kamus; Renaud Piarroux; Sébastien Imbert
Journal:  Antimicrob Agents Chemother       Date:  2021-02-16       Impact factor: 5.191

2.  Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non-COVID-19 patients.

Authors:  Bircan Kayaaslan; Fatma Eser; Ayşe Kaya Kalem; Zeynep Bilgic; Dilek Asilturk; Imran Hasanoglu; Muge Ayhan; Yasemin Tezer Tekce; Deniz Erdem; Sema Turan; Ipek Mumcuoglu; Rahmet Guner
Journal:  Mycoses       Date:  2021-06-16       Impact factor: 4.931

3.  Modified Pitt bacteremia score for predicting mortality in patients with candidaemia: A multicentre seven-year retrospective study conducted in Japan.

Authors:  Nana Nakada-Motokawa; Taiga Miyazaki; Takashi Ueda; Yuka Yamagishi; Koichi Yamada; Hideki Kawamura; Hiroshi Kakeya; Hiroshi Mukae; Hiroshige Mikamo; Yoshio Takesue; Shigeru Kohno
Journal:  Mycoses       Date:  2021-10-23       Impact factor: 4.931

4.  Evaluation of an optimized method to directly identify bacteria from positive blood cultures using MALDI-TOF mass spectrometry.

Authors:  Youhua Yuan; Junjie Wang; Jiangfeng Zhang; Bing Ma; Shanjun Gao; Yi Li; Shanmei Wang; Baoya Wang; Qi Zhang; Nan Jing
Journal:  J Clin Lab Anal       Date:  2019-11-13       Impact factor: 2.352

5.  Evaluation of Rapid Sepsityper® protocol and specific MBT-Sepsityper module (Bruker Daltonics) for the rapid diagnosis of bacteremia and fungemia by MALDI-TOF-MS.

Authors:  Léa Ponderand; Patricia Pavese; Danièle Maubon; Emmanuelle Giraudon; Thomas Girard; Caroline Landelle; Max Maurin; Yvan Caspar
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-12-09       Impact factor: 3.944

6.  Mucosal Bacteria Modulate Candida albicans Virulence in Oropharyngeal Candidiasis.

Authors:  M Bertolini; R Vazquez Munoz; L Archambault; S Shah; J G S Souza; R C Costa; A Thompson; Y Zhou; T Sobue; A Dongari-Bagtzoglou
Journal:  mBio       Date:  2021-08-17       Impact factor: 7.867

7.  Adherence to National Consensus Guidelines and Association with Clinical Outcomes in Patients with Candidemia.

Authors:  Shauna Jacobson Junco; Sarah Chehab; Amanda Giancarelli; Mary Catherine Bowman; R Brigg Turner
Journal:  Infect Dis (Auckl)       Date:  2021-06-07

8.  A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidaemia among paediatric and adult inpatients in a tertiary teaching hospital in China.

Authors:  Zhangrui Zeng; Yinhuan Ding; Gang Tian; Kui Yang; Jian Deng; Guangrong Li; Jinbo Liu
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-14       Impact factor: 4.887

9.  Evaluation of the updated "Candida score" with Sepsis 3.0 criteria in critically ill patients.

Authors:  Dongkai Li; Jiahui Zhang; Wen Han; Guangxu Bai; Wei Cheng; Na Cui
Journal:  Ann Transl Med       Date:  2020-08

10.  The Overlooked Immune State in Candidemia: A Risk Factor for Mortality.

Authors:  Christian Ortega-Loubon; Beatriz Cano-Hernández; Rodrigo Poves-Alvarez; María Fe Muñoz-Moreno; Patricia Román-García; Sara Balbás-Alvarez; Olga de la Varga-Martínez; Esther Gómez-Sánchez; Estefanía Gómez-Pesquera; Mario Lorenzo-López; Eduardo Tamayo; María Heredia-Rodríguez
Journal:  J Clin Med       Date:  2019-09-20       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.